Bayer AG

Bayer AG is a company in Leverkusen, Germany that has taken part in 4 EU-funded projects since 2023.

EU funding receivedNot recorded
EU projects4
As coordinator0
Running now4
First EU project2023
Latest project2025
CountryGermany
EU registration (PIC)997419573
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Bayer AG's own share of each project, not the project's full budget.

  • Horizon Europe€0 · 3 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

4 EU-funded projects, newest first. Each links to the official record.

  • BioTransformAssociated partner

    Mapping the Uncharted Human Metabolism for Novel Food Bioactives

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • SuCatAssociated partner

    Sustainable Catalysis

    Erasmus+ (ERASMUS+) · 2025–2031 · Project on the EU portal ↗

  • MC4DDAssociated partner

    Macrocycles for Drug Discovery

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • rePLANTAssociated partner

    Reconstruction Biology in Plant Sciences Doctoral Training Program

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • drug discovery
  • ecosystems
  • genetics
  • nutrition
  • pathology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime